TECOGEN INC/WALTHAM MA (TGEN) Stock Fundamental Analysis
USA - NYSEARCA:TGEN - US87876P2011 - Common Stock
9.35 USD
-0.38 (-3.91%)
8.95 USD
-0.4 (-4.28%)
Taking everything into account, TGEN scores 3 out of 10 in our fundamental rating. TGEN was compared to 41 industry peers in the Building Products industry. TGEN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, TGEN is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
TGEN had negative earnings in the past year.
In the past year TGEN had a positive cash flow from operations.
In the past 5 years TGEN reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: TGEN reported negative operating cash flow in multiple years.
1.2 Ratios
TGEN has a Return On Assets of -15.31%. This is amonst the worse of the industry: TGEN underperforms 87.80% of its industry peers.
TGEN's Return On Equity of -46.53% is on the low side compared to the rest of the industry. TGEN is outperformed by 87.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.31% | ||
| ROE | -46.53% | ||
| ROIC | N/A |
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of TGEN (43.64%) is better than 82.93% of its industry peers.
In the last couple of years the Gross Margin of TGEN has grown nicely.
The Profit Margin and Operating Margin are not available for TGEN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
2. Health
2.1 Basic Checks
TGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TGEN has been increased compared to 1 year ago.
Compared to 5 years ago, TGEN has more shares outstanding
TGEN has a worse debt/assets ratio than last year.
2.2 Solvency
TGEN has an Altman-Z score of 6.64. This indicates that TGEN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.64, TGEN is in the better half of the industry, outperforming 75.61% of the companies in the same industry.
The Debt to FCF ratio of TGEN is 0.63, which is an excellent value as it means it would take TGEN, only 0.63 years of fcf income to pay off all of its debts.
TGEN has a better Debt to FCF ratio (0.63) than 87.80% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that TGEN is not too dependend on debt financing.
TGEN's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. TGEN outperforms 73.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.63 | ||
| Altman-Z | 6.64 |
ROIC/WACCN/A
WACC9.24%
2.3 Liquidity
TGEN has a Current Ratio of 1.32. This is a normal value and indicates that TGEN is financially healthy and should not expect problems in meeting its short term obligations.
TGEN has a Current ratio of 1.32. This is in the lower half of the industry: TGEN underperforms 75.61% of its industry peers.
TGEN has a Quick Ratio of 1.32. This is a bad value and indicates that TGEN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.74, TGEN is not doing good in the industry: 85.37% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
The earnings per share for TGEN have decreased strongly by -220.48% in the last year.
TGEN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.46%.
The Revenue has been decreasing by -5.52% on average over the past years.
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%54.33%
3.2 Future
The Earnings Per Share is expected to grow by 38.30% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 22.20% on average over the next years. This is a very strong growth
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y-20.14%
EPS Next 5Y38.3%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y1.41%
Revenue Next 5Y22.2%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
TGEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TGEN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, TGEN is valued a bit more expensive than 70.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 89.8 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as TGEN's earnings are expected to decrease with -20.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.69%
EPS Next 3Y-20.14%
5. Dividend
5.1 Amount
TGEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
9.35
-0.38 (-3.91%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners15.06%
Inst Owner Change11.84%
Ins Owners23.08%
Ins Owner Change2.88%
Market Cap277.60M
Revenue(TTM)25.00M
Net Income(TTM)-4760300
Analysts82.86
Price Target15.3 (63.64%)
Short Float %6.78%
Short Ratio1.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.96%
Min Revenue beat(2)-33.4%
Max Revenue beat(2)-30.52%
Revenue beat(4)0
Avg Revenue beat(4)-30.88%
Min Revenue beat(4)-39.65%
Max Revenue beat(4)-19.94%
Revenue beat(8)2
Avg Revenue beat(8)-17.83%
Revenue beat(12)3
Avg Revenue beat(12)-15.77%
Revenue beat(16)4
Avg Revenue beat(16)-15.85%
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-189.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-49.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 12.27 | ||
| P/FCF | 89.8 | ||
| P/OCF | 68.36 | ||
| P/B | 27.13 | ||
| P/tB | 51.69 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)0.1
FCFY1.11%
OCF(TTM)0.14
OCFY1.46%
SpS0.76
BVpS0.34
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.31% | ||
| ROE | -46.53% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.64% | ||
| FCFM | 13.67% |
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
F-Score4
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.63 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 175.01% | ||
| Cap/Sales | 4.28% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | 6.64 |
F-Score4
WACC9.24%
ROIC/WACCN/A
Cap/Depr(3y)87.45%
Cap/Depr(5y)67.63%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y-20.14%
EPS Next 5Y38.3%
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%54.33%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y1.41%
Revenue Next 5Y22.2%
EBIT growth 1Y2.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.59%
EBIT Next 3Y70.17%
EBIT Next 5YN/A
FCF growth 1Y457.51%
FCF growth 3Y112.98%
FCF growth 5YN/A
OCF growth 1Y596.53%
OCF growth 3Y105.19%
OCF growth 5YN/A
TECOGEN INC/WALTHAM MA / TGEN FAQ
What is the fundamental rating for TGEN stock?
ChartMill assigns a fundamental rating of 3 / 10 to TGEN.
Can you provide the valuation status for TECOGEN INC/WALTHAM MA?
ChartMill assigns a valuation rating of 0 / 10 to TECOGEN INC/WALTHAM MA (TGEN). This can be considered as Overvalued.
What is the profitability of TGEN stock?
TECOGEN INC/WALTHAM MA (TGEN) has a profitability rating of 2 / 10.
How financially healthy is TECOGEN INC/WALTHAM MA?
The financial health rating of TECOGEN INC/WALTHAM MA (TGEN) is 5 / 10.
Can you provide the expected EPS growth for TGEN stock?
The Earnings per Share (EPS) of TECOGEN INC/WALTHAM MA (TGEN) is expected to decline by -53% in the next year.